ING5 Inhibits Aerobic Glycolysis of Lung Cancer Cells by Promoting TIE1-mediated Phosphorylation of Pyruvate Dehydrogenase Kinase 1 at Y163

Overview

Journal Front Med

Specialty General Medicine

Date 2024 Sep 13

PMID 39269568

Authors

Haihua Zhang

Xinli Liu

Junqiang Li

Jin Meng

Wan Huang

Xuan Su

Xutao Zhang

Guizhou Gao

Xiaodong Wang

Haichuan Su

Feng Zhang

Tao Zhang

Affiliations

Soon will be listed here.

Abstract

Aerobic glycolysis is critical for tumor growth and metastasis. Previously, we have found that the overexpression of the inhibitor of growth 5 (ING5) inhibits lung cancer aggressiveness and epithelial-mesenchymal transition (EMT). However, whether ING5 regulates lung cancer metabolism reprogramming remains unknown. Here, by quantitative proteomics, we showed that ING5 differentially regulates protein phosphorylation and identified a new site (Y163) of the key glycolytic enzyme PDK1 whose phosphorylation was upregulated 13.847-fold. By clinical study, decreased p-PDK1Y163 was observed in lung cancer tissues and correlated with poor survival. p-PDK1Y163 represents the negative regulatory mechanism of PDK1 by causing PDHA1 dephosphorylation and activation, leading to switching from glycolysis to oxidative phosphorylation, with increasing oxygen consumption and decreasing lactate production. These effects could be impaired by PDK1Y163F mutation, which also impaired the inhibitory effects of ING5 on cancer cell EMT and invasiveness. Mouse xenograft models confirmed the indispensable role of p-PDK1Y163 in ING5-inhibited tumor growth and metastasis. By siRNA screening, ING5-upregulated TIE1 was identified as the upstream tyrosine protein kinase targeting PDK1Y163. TIE1 knockdown induced the dephosphorylation of PDK1Y163 and increased the migration and invasion of lung cancer cells. Collectively, ING5 overexpression-upregulated TIE1 phosphorylates PDK1Y163, which is critical for the inhibition of aerobic glycolysis and invasiveness of lung cancer cells.

Citing Articles

Developing hypoxia and lactate metabolism-related molecular subtypes and prognostic signature for clear cell renal cell carcinoma through integrating machine learning.

Liu J, Yang T, Liu J, Hao X, Guo Y, Luo S Discov Oncol. 2024; 15(1):653.

PMID: 39538070 PMC: 11561225. DOI: 10.1007/s12672-024-01543-7.

References

Yuan M, Zhao Y, Arkenau H, Lao T, Chu L, Xu Q . Signal pathways and precision therapy of small-cell lung cancer. Signal Transduct Target Ther. 2022; 7(1):187. PMC: 9200817. DOI: 10.1038/s41392-022-01013-y. View

Doyon Y, Cayrou C, Ullah M, Landry A, Cote V, Selleck W . ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol Cell. 2006; 21(1):51-64. DOI: 10.1016/j.molcel.2005.12.007. View

Anwar S, Shamsi A, Mohammad T, Islam A, Hassan M . Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy. Biochim Biophys Acta Rev Cancer. 2021; 1876(1):188568. DOI: 10.1016/j.bbcan.2021.188568. View

Cui S, Liao X, Ye C, Yin X, Liu M, Hong Y . ING5 suppresses breast cancer progression and is regulated by miR-24. Mol Cancer. 2017; 16(1):89. PMC: 5424299. DOI: 10.1186/s12943-017-0658-z. View

Ghafouri-Fard S, Taheri M, Baniahmad A . Inhibitor of Growth Factors Regulate Cellular Senescence. Cancers (Basel). 2022; 14(13). PMC: 9264871. DOI: 10.3390/cancers14133107. View

Archambeau J, Blondel A, Pedeux R . Focus-ING on DNA Integrity: Implication of ING Proteins in Cell Cycle Regulation and DNA Repair Modulation. Cancers (Basel). 2019; 12(1). PMC: 7017203. DOI: 10.3390/cancers12010058. View

Wang F, Wang A, Chesnelong C, Yang Y, Nabbi A, Thalappilly S . ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways. Oncogene. 2017; 37(3):286-301. PMC: 5799773. DOI: 10.1038/onc.2017.324. View

Ormaza G, Rodriguez J, de Opakua A, Merino N, Villate M, Gorrono I . The Tumor Suppressor ING5 Is a Dimeric, Bivalent Recognition Molecule of the Histone H3K4me3 Mark. J Mol Biol. 2019; 431(12):2298-2319. DOI: 10.1016/j.jmb.2019.04.018. View

Zhang F, Zhang X, Meng J, Zhao Y, Liu X, Liu Y . ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer. Oncotarget. 2015; 6(18):16239-52. PMC: 4599267. DOI: 10.18632/oncotarget.3842. View

10.

Liu X, Zhang X, Meng J, Zhang H, Zhao Y, Li C . ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways. Oncotarget. 2017; 8(33):54265-54276. PMC: 5589578. DOI: 10.18632/oncotarget.17346. View

11.

Zhang T, Meng J, Liu X, Zhang X, Peng X, Cheng Z . ING5 differentially regulates protein lysine acetylation and promotes p300 autoacetylation. Oncotarget. 2018; 9(2):1617-1629. PMC: 5788586. DOI: 10.18632/oncotarget.22176. View

12.

Warburg O . On the origin of cancer cells. Science. 1956; 123(3191):309-14. DOI: 10.1126/science.123.3191.309. View

13.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

14.

Pusapati R, Daemen A, Wilson C, Sandoval W, Gao M, Haley B . mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells. Cancer Cell. 2016; 29(4):548-562. DOI: 10.1016/j.ccell.2016.02.018. View

15.

Erdem A, Marin S, Pereira-Martins D, Cortes R, Cunningham A, Pruis M . The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia. Nat Commun. 2022; 13(1):1105. PMC: 8888573. DOI: 10.1038/s41467-022-28737-3. View

16.

Lv L, Lei Q . Proteins moonlighting in tumor metabolism and epigenetics. Front Med. 2021; 15(3):383-403. DOI: 10.1007/s11684-020-0818-1. View

17.

Cenigaonandia-Campillo A, Serna-Blasco R, Gomez-Ocabo L, Solanes-Casado S, Banos-Herraiz N, Del Puerto-Nevado L . Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic mutant colon cancer. Theranostics. 2021; 11(8):3595-3606. PMC: 7914362. DOI: 10.7150/thno.51265. View

18.

Hong S, Lee Y, Park I, Kwon S, Min S, Yoon G . Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis. J Biol Chem. 2019; 294(19):7810-7820. PMC: 6514637. DOI: 10.1074/jbc.RA118.006095. View

19.

Adant I, Bird M, Decru B, Windmolders P, Wallays M, de Witte P . Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction. Mol Metab. 2022; 63:101537. PMC: 9287363. DOI: 10.1016/j.molmet.2022.101537. View

20.

Imanaka S, Shigetomi H, Kobayashi H . Reprogramming of glucose metabolism of cumulus cells and oocytes and its therapeutic significance. Reprod Sci. 2021; 29(3):653-667. DOI: 10.1007/s43032-021-00505-6. View